John is a finance executive with 20+ years working with C-level Executives and board members of public companies, leading several successful transformation initiatives. Before joining HLS Therapeutics, John was CFO at Inca Networks Inc. During his 10-year tenure as CFO of Vecima Networks Inc. (TSX:VCM), he held operational P&L responsibility and monetized non-core assets while acquiring strategic assets to grow the business. Earlier, John held senior financial positions with The Westaim Corporation (TSX:WED), including VP of Corporate Development with Westaim Biomedical Corp. John holds an MBA from the University of British Columbia and a BSc from the University of Victoria. He is also a designated accountant and has served as a corporate board member for venture-backed technology companies, including Vector 12 and LTG Lasertech.